Introduction
The influence of maternal smoking on fetal development has been investigated for almost 30 years [1, 3, 4, 6, 9, 15, 16, 18, 24] . Neonates born to smoking mothers were described as having "Fetal Tobacco Syndrome" (FTS) characterized mainly by a decreased birth weight [17] . Smoking is one of the important sources of cadmium contamination in humans [2, 8, 14, 19, 20] . One cigarette contains from 0.82 to 3.67 g of cadmium, about 10% of which is absorbed by the smoker. Several animal studies have shown a considerable embryofetotoxic activity of cadmium compounds [5, 19] . The placenta seems to be one of the target organs for cadmium toxicity in humans [13] . Relatively high cadmium levels were found in human placental tissue [5, 13, 22, 23] . It has been reported that a rapid and extensive accumulation of cadmium in the placenta leads to both the morphological and functional impairment of this organ [10, 13] . Conflicting opinions exist concerning the placental transfer of cadmium in humans. Some authors state that the human placenta forms an effective biological barrier for cadmium [7, 10, 12] while others offer evidence suggesting that regardless of placental accumulation of this metal, cadmium penetrates the fetal compartment [11, 23] . The present investigation was undertaken in order to demonstrate whether smoking during pregnancy alters the perinatal cadmium burden and if so, what influence this may have on morphometric fetoplacental parameters.
Material and methods
The study population consisted of one hundred healthy parturients and 100 neonates born to them between 37 and 42 weeks of pregnancy in the Institute of Obstetrics and Gynecology (State Clinical Hospital No 4) in Lublin, Poland. Thirtyseven women did not smoke during pregnancy (NSm) and the remaining 63 were current smokers (Sm). The median value of the number of cigarettes smoked daily by the examined gravidas was 6. For the purpose of subsequent analysis, the smoking group was divided into two subgroups: smokers who smoked 6 or less cigarettes per day ("Sm < 6)"; N = 34) and those who smoked more than 6 cigarettes a day ("Sm > 6"; n = 29). The characteristics of the subjects in the smoking groups are given in table I. None of the differences calculated for mean age, parity and the duration of pregnancy between the subgroups of women studied was statistically significant. 
NSm
-nonsmokers Sm < 6 -smokers who smoked 6 or less cigarettes per day Sm > 6 -smokers who smoked more than 6 cigarettes per day * -arithmetic mean ± standard deviation
Maternal and umbilical cord blood samples of cal analysis concerning levels of the metal was approximately 10 ml were collected as part of the performed using the median test and the sign routine procedures concerned with delivery. The test [21] . The application of more "quantitative" cadmium concentration was measured iii whole statistics for the analysis of the laboratory data blood by means of atomic absorption fcpectro-obtained may have included a statistical error metry using the technique detailed elsewhere [26] . since in a relatively high percentage the measured A total of 193 determinations were performed in cadmium concentrations were within the range of 100 samples of maternal blood (MB) and 93 sam-"not detected" (less than 0.001 ppm). This was pies of umbilical cord blood (CB). found in 51.0% of Cd-MB and 52.7% of Cd-CB. Morphometric birth parameters of the neonates The distribution of both Cd-MB and Cd-CB was were compared to the level of maternal smoking found to be skewed to the right, so that the statist!-by means of the t-Student's test. -coefficient of variation * -means differ significantly (at p < 0.05 level of significance) is assigned by different letters (eg. "a" versus "b") NSm -nonsmokers Sm < 6 -smokers who smoked 6 or less cigarettes per day Sm > 6 -smokers who smoked more than 6 cigarettes per day
Results
Table II presents selected fetoplacental parameters related to maternal smoking. The mean birth weight of the neonates born to nonsmoking mothers (3476 ± 434 g), was significantly higher than that of the "Sm > 6" group (3033 ± 360 g) (p < 0.05). The mean placental weight in the nonsmokers was higher than in both subgroups of smokers although these differences were not significant. However, when relative placental weight (placental weight to birth weight ratio χ 100%) was evaluated, the difference between the "Sm > 6" group (20.4 + 4.0%) and the nonsmokers (18.7 + 3.2%) appeared to be statistically significant (p < 0.05). A slight, insignificant decrease in Roher's ponderal index (birth weight (g)/body length (cm) 3 χ 100) was observed in the newborns of smoking mothers as compared to the infants of non-smokers.
Figures 1 and 2 present the distribution of cadmium values determined in MB and CB. Detectable Cd concentrations were found in 27.0% of the blood samples obtained from nonsmoking mothers and in 32.4% of CB samples obtained from their neonates while in the "Sm" group detectable MB and CB cadmium levels were measured in 61.9% and 57.1% of samples respectively. These differences were statistically significant (for Cd-MBp < 0.001 andforCd-CBp < 0.02) ( Figure 1 . The frequency distribution pattern of cadmium Figure 2 . The frequency distribution pattern of cadmium values determined in maternal blood (MB); (NSm -values determined in umbilical cord blood (CB); (for nonsmokers; Sm < 6 -smokers who smoked 6 or less abbreviations see figure 1 ). cigarettes per day; Sm > 6 -smokers who smoked more than 6 cigarettes per day). fetoplacental parameters studied (birth weight, placental weight, relative placental weight and ponderal index) was significantly associated with cadmium levels in MB and CB.
Discussion
The results obtained in this study confirm that the physical development of newborns with the FTS is retarded in comparison to the neonates of nonsmoking mothers [4, 17, 24] . Of the fetoplacental parameters analyzed, the decreased birth weight and higher relative placental weight were found to be associated both with maternal smoking per se as well as with the average number of cigarettes smoked per day. What deserve^ emphasis is that the relative placental weight appeared to be a more sensitive parameter for the diagnosis of the FTS than the absolute value of the placental weight. The Roher's ponderal index which is known to be a useful quantitative measure of the nutritional status at birth [25] did not differ significantly in the subgroups in our study, thus indicating that the growth retardation observed by us in newborns of smokers' could be considered as mild.
Compared to the extensive research efforts concerned with the toxo-clinical evaluation of other tobacco smoke compounds, relatively little interest has been focussed in perinatal medicine on the cadmium burden caused by maternal smoking [10, 11, 12] . The results obtained by us confirm that smoking during pregnancy leads to elevated cadmium concentration in both the mother and the fetus. The perinatal cadmium burden did not differ significantly in the subgroups of smokers examine (table IV) . The relatively low average number of cigarettes smoked daily by our patients may have contributed to this result. It would be of interest to examine these relationships in a population of heavy smokers (in our study group only 1 patient smoked more than 20 cigarettes per day). Of the possible sources of cadmium in the non-smoking mothers, dietary intake and atmospheric air pollution seem to be of major importance. Our findings with respect to cadmium levels on both sides of the placenta seem contrasting to the opinion that an effective placental barrier for cadmium exists which protects the unborn child from this toxic metal [7, 10, 12] . The excellent, positive correlation established in the present study between Cd-MB and Cd-CB (p < 0.001) as well as the insignificant difference between cadmium levels measured in the mother and the fetus support the opinion that maternal exposure to cadmium poses a potential hazard for the developing fetus due to transplacental exposure to this highly toxic element.
The lack of significant association between blood cadmium and the analyzed birth parameters of the newborn indicates that the elevated cadmium burden in the smoking group did not directly affect the intrauterine growth of these neonates. Undoubtedly other associated with smoking factors such as the effects of nicotine, carbon monoxide and cyanide exposure, suppressed aryl hydrocarbon activity etc. play a role in the etiology of the FTS. The importance of chronic cadmium exposure as a factor resulting in the well described prenatal consequences of maternal smoking remains to be clarified. The association between maternal smoking and both morphometric birth parameters and the perinatal cadmium burden were studied. The cadmium concentrations were measured by atomic absorption spectrometry in 100 samples of materaal whole blood (MB) and in 93 samples of umbilical cord blood (CB). In the group of nonsmokers, significantly higher birth weight and decreased relative placental weight were noted as compared to the group of smokers who smoked more than 6 cigarettes a day (p < 0.05). In both maternal and cord blood samples, the measured Cd levels were found to be significantly higher in smokers than in the nonsmoking subjects (for MB and CB p < 0.01 and p < 0.01 respectively). The average number of cigarettes smoked daily by the women had little effect on the levels of the metal. The Cd-MB strongly correlated with the Cd-CB (p < 0.001). The cadmium values determined in MB and CB did not significantly affect any of the studied fetoplacental parameters. The reported findings give support for placental permeability to cadmium in humans and confirm that smoking during pregnancy leads to elevated Cd concentrations in both the mother and the fetus.
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